Predictors for mucormycosis in COVID era: A case-control study from Gujarat

CONTEXT: Mucormycosis has been increasingly described in the coronavirus disease (COVID-19) era, however, there is a lack of robust epidemiological studies to understand the predictors for the development of mucormycosis from India. AIMS: To document the risk factors of mucormycosis with or without...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Poonam, Memon, Farjana, Shah, Komal, Shah, Hemal, Yasobant, Sandul, Saxena, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648231/
https://www.ncbi.nlm.nih.gov/pubmed/36387637
http://dx.doi.org/10.4103/jfmpc.jfmpc_2138_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648231/
https://www.ncbi.nlm.nih.gov/pubmed/36387637
http://dx.doi.org/10.4103/jfmpc.jfmpc_2138_21

Ejemplares similares